Lactic acidosis secondary to antiretroviral therapy in patients with HIV/AIDS

Authors

  • Benhard Hasbum Fernández Caja Costarricense del Seguro Social, Hospital México
  • Jose Rojas Solano Caja Costarricense del Seguro Social, Hospital México
  • Luis Gutiérrez Jaikel Caja Costarricense del Seguro Social, Hospital México
  • María Paz León Bratti Caja Costarricense del Seguro Social, Hospital México

DOI:

https://doi.org/10.51481/amc.v48i2.247

Keywords:

actic acidosis, antiretroviral therapy, lactate, L- carnitine

Abstract

Lactic acidosis is a rare complication of antiretroviraltreatment for HIV. Its occurrence has been related to the useof transcriptase reverse nucleoside analogues, especiallyestavudine and didanosine. We present here 2 cases of HIVpatients who suffered lactic acidosis and were treated at theInternal Medicine Department of the Hospital Mexico, SanJose, Costa Rica. Both cases had a fatal evolution, despitethat both received all the therapeutic measures recommended in the literatura.

Downloads

Download data is not yet available.

References

ONUSIDA. Informe sobre la epidemia mundial de SIDA. Cuartoinforme mundial. UNAIDS/04.168. 2004. pp 87.

Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, SchooleyRT, Haubrick TH, et al. A trial comparing nucleoside monotherapywith combination therapy in HIV-infected adults with CD4 cellcounts from 200 to 500 per cubic millimeter. N Engl J Med 1996,335:1081-1090

Imhof A, Ledergerber B, Gunthard HF, Haupts S, Weber R, SwissHIV Cohort Study. Risk Factors for and Outcome of Hyperlactatemiain HIV-Infected Persons: Is There a Need for Routine LactateMonitoring ?. Clin Infect Dis 2005;41:721-728

Bartlett JG, Gallant JE. Medical management of HIV. Johns HopkinsMedicine. 2004. pp 478.

Cote HC, Brumme ZL, Craib KJ, Alexander CS, Wynnoven B, TingL et al. Changes in mitochondrial DNA as a marker of nucleoside tox-icity in HIV-infected patients. N Engl J Med 2002; 346:811-820.

John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ,Mallal SA. Chronic hyperlactatemia in HIV infected patients takingantiretroviral therapy. AIDS 2001;15:717-723

Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. NatMed 1995;1:417-422.

Olano JP, Borucki MJ, Wen JW. Massive hepatic steatosis and lacticacidosis in a patient with AIDS who was receiving zidovudine. ClinInfect Dis 1995;21:973-976

Lenzo NP, Garas BA, French MA: Hepatic steatosis and lactic acido-sis associated with stavudine treatment in a HIV patient :a case report.AIDS 1997; 11:1294-1296

Brinkman K, Vrouenraets S, Kauffmann R, Weigel H, Frissen J.Treatment of nucleoside reverse transcriptase inhibitor induced lacticacidosis. AIDS 2000, 14:2801-2802.

Claessens YE, Chiche JD, Mira JP, Cariou A. Bench-to-bedsidereview: Severe lactic acidosis in HIV patients treated with nucleosideanalogue reverse transcriptase inhibitors. Critical Care 2003; 7:226-232.

Downloads

Published

2006-04-01

Issue

Vol. 48 No. 2 (2006): Acta Médica Abril-Mayo 2006

Section

Caso Clínico

License

Copyright (c) 2008 Acta Médica Costarricense

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)

How to Cite

Lactic acidosis secondary to antiretroviral therapy in patients with HIV/AIDS. (2006). Acta Médica Costarricense , 48(2), 88-90. https://doi.org/10.51481/amc.v48i2.247